Abstract：Objective To investigate the clinical effect of Ligustrazine Injection combined with Edaravone in the treatment of cerebral vasospasm after intracranial aneurysm surgery. Methods A total of 100 patients with cerebral vasospasm after intracranial aneurysm surgery were selected from Chifeng Municipal Hospital, Inner Mongolia Autonomous Region from January 2017 to December 2019. They were divided into control group and study group according to the random number table method, with 50 cases in each group. The control group was treated with Edaravone and the study group was treated with Ligustrazine Injection on the basis of the control group. The efficacy, nervous function, middle cerebral artery blood flow velocity (VMCA), serum related indexes and adverse reactions were compared between the two groups. Results After four weeks of treatment, the clinical total effective rate of the study group was higher than that of the control group (P ＜ 0.05). After four weeks of treatment, the score of national Institutes of health stroke scale (NIHSS), the levels of interleukin-6 (IL-6), tumor necrosis factor -α (TNF-α), endothelin-1 (ET-1) in the two groups were lower than those before treatment, and the study group was lower than the control group (P ＜ 0.05). After four weeks of treatment, the levels of nitric oxide (NO) and VMCA in the two groups were higher than those before treatment (P < 0.05), and the study group was higher than that in the control group (P ＜ 0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P ＞ 0.05). Conclusion Ligustrazine Injection combined with Edaravone is effective in the treatment of cerebral vasospasm after intracranial aneurysm surgery. It can promote the improvement of the body’s nervous function, restore blood flow speed, and it is safe and reliable. It may be related to the improvement of the body’s IL-6, TNF-α, ET-1 and NO levels.
陈立波 朱迪 梁旭光. 川芎嗪注射液联合依达拉奉治疗颅内动脉瘤术后脑血管痉挛的效果[J]. 中国医药导报, 2020, 17(35): 80-83.
CHEN Libo ZHU Di LIANG Xuguang. Effect of Ligustrazine Injection combined with Edaravone in the treatment of cerebral vasospasm after intracranial aneurysm surgery. 中国医药导报, 2020, 17(35): 80-83.
[1] Fan H，Yang C，Jia C，et al. miR-566 expression and immune changes in patients with intracranial aneurysm [J].Int J Clin Exp Pathol，2020，13（4）：685-691.
[2] Heo J，Park SJ，Kang SH，et al. Prediction of Intracranial Aneurysm Risk using Machine Learning [J]. Sci Rep，2020， 10（1）：6921.
[3] 张玉清，陶立玉，张子轩.颅内动脉瘤破裂出血术后血清HIF-1α、miR-210表达与脑血管痉挛的关系[J].中华神经创伤外科电子杂志，2020，6（1）：4-8.
[4] Eliava SS，Belousova OB，Pilipenko YV，et al. Surgical treatment of patients with cerebral aneurysms in the acute stage of rupture: dynamics of results during 2006-2018 [J].Zh Vopr Neirokhir Im N N Burdenko，2019，83（5）：5-13.
[5] 万晓强，雷波，郑念东，等.纳美芬联合依达拉奉对颅内动脉瘤血管栓塞术后患者的神经功能及血清NSE、MMP-2、ET-1影响观察[J].中国药师，2020，23（1）：107-109.
[6] 谭占国，黄圣明.蛛网膜下腔出血后迟发脑血管痉挛诊治新进展[J].中国临床神经外科杂志，2019，24（8）：505-506，510.
[7] Naess H，Kurtz M，Thomassen L，et al. Serial NIHSS Scores in Patients With Acute Cerebral Infarction [J]. Acta Neurol Scand，2016，133（6）：415-420.
[8] 章学媛，王益丽.丹参注射液联合尼莫地平对颅内动脉瘤栓塞术后脑血管痉挛的防治作用观察[J].中国中医药科技，2016，23（6）：729-730.
[9] Elgebaly AS，Abd El Ghafar MS，Fathy SM，et al. Vasopressin Continuous Infusion Improves Intracranial Pressure and Patient Outcomes after Surgical Clipping or Endovascular Coiling of Cerebral Aneurysm [J]. Anesth Essays Res，2019，13（3）：528-534.
[10] Campe C，Neumann J，Sandalcioglu IE，et al. Vasospasm and delayed cerebral ischemia after uneventful clipping of an unruptured intracranial aneurysm - a case report [J]. BMC Neurol，2019，19（1）：226.
[11] 胡震，林生，黄文立，等.丁苯酞联合前列地尔治疗动脉瘤性蛛网膜下腔出血伴脑血管痉挛患者的疗效观察[J].广西医科大学学报，2019，36（7）：1143-1147.
[12] Brami J，Chousterman B，Boulouis G，et al. Delayed Cerebral Infarction is Systematically Associated with a Cerebral Vasospasm of Large Intracranial Arteries [J]. Neurosurgery，2020，86（2）：E175-E183.
[13] 杨彦昊，李宏宇.川芎嗪注射液联合尼莫地平治疗颅内动脉瘤术后脑血管痉挛的疗效及对血浆IL-6、TNF-α、ET-1、NO水平的影响[J].中西医结合心脑血管病杂志，2019，17（20）：3218-3222.
[14] Munakata A，Ohkuma H，Shimamura N. Effect of a free radical scavenger, edaravone, on free radical reactions: related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model [J]. Acta Neurochir Suppl，2011，110（Pt 2）：17-22.
[15] 何婉玲，袁惠萍，罗鹏.川芎嗪在颅内动脉瘤介入围手术期脑血管痉挛预防的临床效果观察[J].世界中西医结合杂志，2017，12（4）：524-526.
[16] 秦忠宗，祝刚，罗洪海，等.川芎嗪注射液联合尼莫地平防治破裂颅内动脉瘤栓塞术后脑血管痉挛疗效观察[J].现代中西医结合杂志，2016，（7）：779-781.
[17] 李会兵.川芎嗪注射液对脑动脉瘤介入手术后患者疗效及早期脑氧代谢及氧化应激指标的影响[J].现代中西医结合杂志，2018，27（16）：1784-1787.
[18] 曾凡猛，方凯.川芎嗪联合尼莫地平防治破裂颅内动脉瘤栓塞术后脑血管痉挛的临床研究[J].黑龙江医学，2016，40（12）：1089-1090.
[19] 卢子明.炎症反应在动脉瘤性蛛网膜下腔出血早期脑损伤的作用及治疗进展[J].中国微侵袭神经外科杂志，2020，25（2）：91-93.
[20] 曲良卓.蛛网膜下腔出血颅内血管痉挛及炎症的相关标记物探讨[J].中国实用神经疾病杂志，2018，21（19）：2165-2170.
[21] 李晖，戴孝森，卓开全.尼莫地平与前列地尔联合治疗动脉瘤性蛛网膜下腔出血伴脑血管痉挛患者炎症因子和ET-1、CGRP、VEGF水平的影响[J].脑与神经疾病杂志，2019，27（7）：438-442.
[22] 邹长林.炎症在蛛网膜下腔出血中的作用及机制研究进展[J].国际神经病学神经外科学杂志，2017，44（1）：83-86.
[23] 孙达，常静，林莉莉.川芎嗪治疗急性心肌梗死大鼠的作用机制研究[J].中国临床药理学杂志，2019，35（24）：3208-3212.
[24] Duan Y，An W，Wu Y，et al. Tetramethylpyrazine reduces inflammation levels and the apoptosis of LPS-stimulated human periodontal ligament cells via the downregulation of miR-302b [J]. Int J Mol Med，2020，45（6）：1918-1926.
[25] 吴佩涛，杨瑞廷，欧阳伟.川芎嗪联合高压氧对颅内动脉瘤术后的疗效[J].中国继续医学教育，2019，11（31）：142-144.
2020, Vol. 17 
京公网安备 11010502046598号